Claude Jourdan Le Saux

Uncovering senescent fibroblast heterogeneity connects DNA damage response to idiopathic pulmonary fibrosis

The paper identifies senescent fibroblast heterogeneity in IPF and links it to DNA damage response dysregulation using gene expression analysis.

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

This study identifies age-related epigenetic changes in AT2 cells that promote basal cell metaplasia, contributing to idiopathic pulmonary fibrosis.

Cellular senescence dysregulates antiviral interferon responses in idiopathic pulmonary fibrosis

This study shows that cellular senescence in IPF fibroblasts disrupts antiviral responses, leading to increased viral titers and altered inflammation.

Alveolar Type II Cell-derived MMP1high basal cells promote destructive microcysts in idiopathic pulmonary fibrosis.

The paper identifies MMP1high basal cells derived from alveolar type II cells that contribute to microcyst formation in IPF, suggesting a therapeutic target through MMP inhibition or WNT modulation.

Targeting p16INK4a reverses alveolar epithelial cell dysfunction and induces lung regeneration in emphysema

This study shows that deleting p16INK4a or targeting p16+ cells reverses alveolar epithelial dysfunction and promotes lung regeneration in emphysema.

Inhibition of PIKfyve kinase induces senescent cell death by suppressing lysosomal exocytosis and leads to improved outcomes in a mouse model of idiopathic pulmonary fibrosis

The paper identifies apilimod as a senolytic drug that selectively kills senescent cells by inhibiting lysosomal exocytosis, showing therapeutic benefit in a mouse model of pulmonary fibrosis.

PROPEL: a scalable model for postbaccalaureate training to promote diversity in the biomedical workforce

PROPEL is a postbaccalaureate program that trains scholars from underrepresented backgrounds in biomedical research, demonstrating its scalability and impact.